A Phase 2a, Randomised, Double-Blind, Placebo-Controlled, Multicentre Study to Evaluate the Efficacy, Safety and Tolerability of BG00012 When Given With Methotrexate to Subjects With Active RA Who Have Had an Inadequate Response to Conventional Disease-Modifying Anti-Rheumatic Drug Therapy
Phase of Trial: Phase II
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Dimethyl fumarate (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Biogen
- 17 Mar 2012 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database.
- 06 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Feb 2010 Additional trial centre identified as reported by Clinical Trials Registry - India.